Form 4: W.K. Kellogg Foundation Trust Sells Over 114,000 Shares of Kellanova Stock Under Pre-Arranged Plan

The W.K. Kellogg Foundation Trust, a significant shareholder of Kellanova, reported the sale of 114,583 shares of common stock for approximately $9.4 million, executed under a pre-scheduled 10b5-1 trading plan.

Summary

• The W.K. Kellogg Foundation Trust, identified as a 10% owner and director-affiliated entity of Kellanova (K), reported a transaction on May 28, 2025.
• The transaction involved the disposition (sale) of 114,583 shares of Kellanova common stock.
• The shares were sold at a price of $82.3869 per share, totaling approximately $9,439,999.99.
• Following this transaction, the W.K. Kellogg Foundation Trust beneficially owns 46,472,450 shares of Kellanova common stock.
• The sale was made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024, which are intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The sale of a significant block of shares by a major shareholder, while executed under a pre-arranged 10b5-1 plan, can still be perceived with slight neutrality to mild negativity by the market, as it represents a reduction in insider ownership. The pre-planned nature prevents a strong negative sentiment.

Positives

• The transaction was executed under a Rule 10b5-1(c) trading plan, indicating a pre-scheduled and non-discretionary sale, which can mitigate concerns about insider sentiment compared to an unplanned sale.

Negatives

• A significant sale of 114,583 shares by a major shareholder (10% owner) represents a reduction in insider ownership, which could be perceived negatively by some investors.

Risks

• While executed under a 10b5-1 plan, large insider sales can sometimes lead to negative market sentiment or speculation regarding the company's future prospects, potentially impacting share price.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding Kellanova's future performance or strategic outlook.

Management Comments

• The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024, that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.

Industry Context

This filing is an insider transaction report and does not directly relate to broader industry trends or competitive dynamics, but rather reflects a specific ownership change by a major shareholder.

Related Party Transactions

• The W.K. Kellogg Foundation Trust, identified as a 10% owner of Kellanova, executed a sale of 114,583 shares of common stock to the open market. This transaction constitutes a related party dealing due to the Trust's significant ownership stake and its relationship as a reporting person.

Stakeholder Impact

• Shareholders may observe the reduction in beneficial ownership by a significant institutional investor, which could influence their perception of the stock.

Key Dates

Keywords

Kellanova, K, W.K. Kellogg Foundation Trust, SEC Form 4, Insider Trading, Stock Sale, Beneficial Ownership, 10b5-1 Plan, Equity Securities, Institutional Investor